Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE - H-CYTE, INC. | ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): June 6, 2017
MEDOVEX CORP.
(Exact Name of
Registrant as Specified in Charter)
Nevada
|
|
333-198621
|
|
46-3312262
|
(State or other
jurisdiction of
incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
1950 Airport Road, Suite A
Atlanta, Georgia
|
|
|
|
30341
|
(Address of
principal executive offices)
|
|
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (844) 633-6839
Copies
to:
Harvey Kesner,
Esq.
Arthur S. Marcus,
Esq.
Sichenzia
Ross Ference KesnerLLP
61 Broadway,
32nd Floor
New York, New
York 10006
(212)
930-9700
(212) 930-9725
(fax)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d 2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
FORWARD-LOOKING
STATEMENTS
This Current Report
on Form 8-K contains forward-looking statements. Forward-looking
statements include statements concerning plans, objectives, goals,
strategies, future events or performance, and underlying
assumptions and other statements that are other than statements of
historical facts. These statements are subject to uncertainties and
risks including, but not limited to (i) securing capital for
general working purposes, and (ii) other risks and in statements
filed from time to time with the Securities and Exchange Commission
(the “SEC”). All
such forward-looking statements, whether written or oral, and
whether made by or on behalf of the Company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the Company disclaims any obligation to, and will not,
update any forward-looking statements to reflect events or
circumstances after the date hereof.
Item
7.01 Regulation FD Disclosure
On June 5, 2017,
MedoveX Corp. (the “Company”) issued a press release
(the “Release”)
regarding receipt of CE Mark approval for the DenerveX System,
allowing the Company to market the DenerveX system in
Europe. A copy of the Release is attached hereto and
incorporated herein by reference in its entirety as Exhibit 99.1.
The information
contained in this Current Report on Form 8-K shall not be deemed
“filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by
reference in any filing under the Securities Act of 1933, as
amended (the “Securities
Act”) or the Exchange Act, except as shall be
expressly set forth by specific reference in such a
filing. The furnishing of the information in this
Current Report on Form 8-K is not intended to, and does not,
constitute a representation that such furnishing is required by
Regulation FD or that the information contained in this Current
Report on Form 8-K constitutes material investor information that
is not otherwise publicly available.
The Securities and
Exchange Commission encourages registrants to disclose
forward-looking information so that investors can better understand
the future prospects of a registrant and make informed investment
decisions. This Current Report on Form 8-K and exhibits may contain
these types of statements, which are “forward-looking
statements” within the meaning of the Private Securities
Litigation Reform Act of 1995, and which involve risks,
uncertainties and reflect the Registrant’s judgment as of the
date of this Current Report on Form 8-K. Forward-looking statements
may relate to, among other things, operating results and are
indicated by words or phrases such as “expects,”
“should,” “will,” and similar words or
phrases. These statements are subject to inherent uncertainties and
risks that could cause actual results to differ materially from
those anticipated at the date of this Current Report on Form 8-K.
Investors are cautioned not to rely unduly on forward-looking
statements when evaluating the information presented
within.
Item
9.01 Financial Statements and
Exhibits
(d) Exhibits.
Exhibit
No.
|
|
Description
|
99.1
|
|
Press Release dated
June 5, 2017
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
MEDOVEX CORP.
|
|
|
|
|
Date: June 6,
2017
|
By:
|
/s/ Jarrett Gorlin
Jarrett
Gorlin
Chief Executive
Officer
|